Home > PS Ratio > ASTRAZENECA PHARMA INDIA

ASTRAZENECA PHARMA INDIA
PS (Price/Sales) Ratio

The Current P/S Ratio of ASTRAZENECA PHARMA INDIA is 10.74.

Share Price ₹6,375.5Dec 27,2024
Market Cap ₹15,938.6 Cr
Sales-TTM₹1,484.5 CrTTM-Standalone Results
Price/Sales10.74xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for ASTRAZENECA PHARMA INDIA
Please provide your vote to see the results
ASTRAZENECA PHARMA INDIA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals

Definition & Calculation of PS (Price/Sales) ratio of ASTRAZENECA PHARMA INDIA

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of ASTRAZENECA PHARMA INDIA is calculated as :

Current Market Cap [ ₹15,938.6 Cr] as on Dec 27,2024

(/) Sales [ ₹1,484.5 Cr] based on TTM-Standalone Results

(=) P/S Ratio [ 10.74x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for ASTRAZENECA PHARMA INDIA , the investors are currently willing to pay '10.74 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of ASTRAZENECA PHARMA INDIA !

The chart below summarizes the trend in P/S Ratio of ASTRAZENECA PHARMA INDIA over the last five years.

Historical PS (Price/Sales) ratio chart of ASTRAZENECA PHARMA INDIA


PS Ratio Performance Analysis for ASTRAZENECA PHARMA INDIA

- ASTRAZENECA PHARMA INDIA 's latest p/e ratio is 10.74x.

- ASTRAZENECA PHARMA INDIA 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 8.55x.

- ASTRAZENECA PHARMA INDIA 's operated at median p/e ratio of 8.09x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, ASTRAZENECA PHARMA INDIA 's p/e ratio peaked in Mar2024 at 10.27x.

- ASTRAZENECA PHARMA INDIA 's p/e ratio hit its five-year low in Mar2020 of 7.19x.


How does ASTRAZENECA PHARMA INDIA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
ASTRAZENECA PHARMA INDIA 1,484.510.7415,938.6
SUN PHARMACEUTICAL INDUSTRIES LTD50,307.78.88446,684.0
CIPLA LTD26,512.04.59121,639.0
DR REDDYS LABORATORIES LTD30,084.93.85115,931.0
ZYDUS LIFESCIENCES LTD21,483.54.5697,876.4
DIVIS LABORATORIES LTD8,614.018.10155,935.0
MANKIND PHARMA LTD11,018.010.76118,539.0
TORRENT PHARMACEUTICALS LTD11,225.010.27115,269.0
LUPIN LTD21,431.34.74101,649.0
AUROBINDO PHARMA LTD30,295.02.4473,785.0
ABBOTT INDIA LTD6,066.110.2662,260.6

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs ASTRAZENECA PHARMA INDIA 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.44x
Max industry PS 18.10x
Median industry PS 8.88x
Average industry PS 8.11x



You may also like the below Video Courses